The company had focused its resources on Filspari’s launch in IgAN after the US ...
Onward Medical revealed that it has received a major grant from the Christopher ...
In a decision expected to limit Brussels’ merger authority, American gene sequen...
Sanofi has announced that tolebrutinib, a BTK inhibitor, failed in two out of th...
Athira Pharma’s Phase 2/3 Alzheimer’s disease trial has ended in failure. The tr...
NHS England has announced the availability of MSD UK’s belzutifan, a take-at-hom...
The UK government has taken a step towards banning xylazine and 21 other substan...
ArsenalBio has secured $325m in a Series C financing round to propel its program...
Eli Lilly and EVA Pharma have formed a partnership to increase the availability ...
A panel of researchers gave presentations on the clinical evidence for the role ...
The subanalyses recontextualised data from the PACMAN-AMI trial on the therapeut...
Haya could secure up to $1bn after hitting preclinical, clinical, and commercial...
Moderna is currently running a Phase I/II trial of the mRNA mpox vaccine mRNA-17...
eGenesis conducted the first-in-human porcine kidney transplant earlier this yea...
When people think of collagen, they typically think of the skin. This is a fair ...
